| Term 
 | Definition 
 
        | Bacteriacidal by inhibiting cell wall synthesis by preventing cross-linking of peptidoglycan chain General structure: thiazolidine ring and beta-lactam ring
 R group affects stability and resistance
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Potent inhibitor of beta-lactamases Decreases penicillin resistance
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Bacteriacidal by inhibiting cell wall synthesis Not stable in acid, narrow spectrum of action
 For Gram +ve bacteria
 Penicillin G benzathine delays absorption (maintains serum levels for 10 days)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Bacteriacidal by inhibiting cell wall synthesis Stable in acid
 Similar to Penicillin G
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Bacteriacidal by inhibiting cell wall synthesis Stable in acid and beta-lactamase resistant
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Bacteriacidal by inhibiting cell wall synthesis Stable in acid but susceptible to beta-lactamase
 Broad spectrum for both Gram +ve and Gram -ve bacteria
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Bacteriacidal by inhibiting cell wall synthesis Stable in acid but susceptible to beta-lactamase
 Broad spectrum for both Gram +ve and Gram -ve bacteria
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Aminoglycosides Bactericidal via irreversible inhibition of protein synthesis via binding to 30S ribosome
 Used against Gram -ve enteric bacteria, often with penicillins
 Irreversible damage to cochlear/vestibular cells, reversible damage to kidney tubules
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Broad spectrum bacteriostatic via reversible binding to 30S ribosome at t-RNA acceptor site Readily binds to Ca2+ in newly formed bones & teeth
 Reduced bone growth and discolouration of teeth in children & new offspring
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Bacteriostatic & reversible, first antibiotic used Structural analog of p-aminobenzoic acid (PABA)
 Competitive inhibition of dihydropteroate synthase for synthesis of folic acid
 Inhibit both Gram +ve and -ve
 Short-acting for UTIs
 Insoluble for ulcerative colitis and IBD
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Inhibits bacterial dihydrofolate reductase for synthesis of nucleic acids Often used in combination with a sulfonamide
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Quinolone Inhibits bacterial topoisomerase II required for transcription and DNA replication
 Broad spectrum, many are b-lactam resistant
 Used to treat complicated UTIs, Gram -ve infections but commonly misused & overused
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | DNA polymerase inhibitor Used to treat DNA viruses (Herpes, CMV)
 Phosphorylation required
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Nucleoside/tide reverse transcriptase inhibitor (NRTI) Deoxythymidine analog
 Competitive inhibitor of HIV reverse transcriptase & chain termination
 Phosphorylated 3X
 Used to treat retroviruses (HIV)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Nucleoside/tide reverse transcriptase inhibitor (NRTI) Cytosine analog
 Competitive inhibitor of HIV reverse transcriptase & chain termination
 Phosphorylated 3X
 Used to treat retroviruses (HIV)
 |  | 
        |  | 
        
        | Term 
 
        | Neviraprine Delavirdine
 Efavirenz
 |  | Definition 
 
        | Nonnucleoside reverse transcriptase inhibitors (NNRTIs) Noncompetitive inhibitors of transcriptase via enzymatic conformational change
 Must be combined with 2 other agents
 Used to treat retroviruses (HIV)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Protease inhibitor Prevents production of mature virion
 Metabolized by, and inhibits cytochrome P450 3A4
 Used to treat retroviruses (HIV)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Fusion inhibitor Used to treat retroviruses (HIV)
 Binds to gp41 subunit of viral envelope protein
 Prevents fusion of viral and host cell memrbanes
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | CCR5 receptor antagonists Used to treat retroviruses (HIV) in patients infected with treatment-resistant strains
 Binds to CCR5 chemokine co-receptor
 Prevents fusion of viral and host cell membranes
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Integrase inhibitor Used to treat retroviruses (HIV) in patients infected with treatment-resistant strains
 Binds to viral intgegrase & inhibits integration of viral DNA into host chromosome
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Used to treat influenza (prophylaxis) in high-risk patients Inhibits viral proton channel M2 involved in fusion with endosome membrane & dissociation of ribonucleoprotein (uncoating)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Neuroaminidase inhibitor Binds to active sites & prevents release of virions from host
 Used to treat influenza (effective in all strains)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Nucleoside/nucleotide analog Inhibits translation of viral mRNA
 Used to treat hepatitis (HBV, HCV)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | HCV-specific protease inhibitors |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Blocks tubular secretion of penicillin |  | 
        |  |